Selective inhibition of vascular smooth muscle cell proliferation by coptisine isolated from Coptis rhizoma, one of the crude drugs composing Kampo medicines Unsei-in

Phytomedicine

Volumn 13, Issue 5, 2006, Pages 334-342

  Tanabe, H ^a   Suzuki, H ^a   Nagatsu, A ^a   Mizukami, H ^a   Ogihara, Y ^b   Inoue, M ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b MEIJO UNIVERSITY   (Japan)

Author keywords

Coptis rhizoma; Coptisine; Growth inhibition; Kampo medicine; Vascular smooth muscle cell

Indexed keywords

ALKALOID; BERBERINE; COPTIS RHIZOME; COPTISINE; HERBACEOUS AGENT; ISOQUINOLINE ALKALOID; PALMATINE; PROTOBERBERINE; UNCLASSIFIED DRUG; UNSEI IN;

ANIMAL CELL; ARTICLE; BIOASSAY; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG ISOLATION; DRUG SCREENING; DRUG SELECTIVITY; EMBRYO; FRACTIONATION; HELA CELL; HEMOSTASIS; HERBAL MEDICINE; HUMAN; HUMAN CELL; INHIBITION KINETICS; JAPAN; MALE; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; TRADITIONAL MEDICINE; VASCULAR SMOOTH MUSCLE;

ANIMALS; BERBERINE; CELL CYCLE; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COPTIS; DRUGS, CHINESE HERBAL; HELA CELLS; HUMANS; INHIBITORY CONCENTRATION 50; MALE; MEDICINE, KAMPO; MELANOMA, EXPERIMENTAL; MICE; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; RHIZOME;

ANIMALIA; COPTIS;

EID: 33646086990     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2005.02.001     Document Type: Article

References (26)

1. Alcocer F., Whitley D., Salazar-Gonzalez J.F., Jordan W.D., Sellers M.T., Eckhoff D.E., Suzuki K., Macrae C., and Bland K.I. Quercetin inhibits human vascular smooth muscle cell proliferation and migration. Surgery 131 (2002) 198-204
2. Chang Y.L., Usami S., Hsieh M.T., and Jiang M.J. Effects of palmatine on isometric force and intracellular calcium levels of arterial smooth muscle. Life Sci. 64 (1999) 597-606
3. Colombo M.L., Bugatti C., Mossa A., Pescalli N., Piazzoni L., Pezzoni G., Menta E., Spinelli S., Johnson F., Gupta R.C., and Dasaradhi L. Cytotoxicity evaluation of natural coptisine and synthesis of coptisine from berberine. Farmaco 56 (2001) 403-409
4. Cushman M., Dekow F.W., and Jacobsen L.B. Conformations, DNA binding parameters, and antileukemic activity of certain cytotoxic protoberberine alkaloids. J. Med. Chem. 22 (1979) 331-333
5. Ferri N., Yokoyama K., Sadilek M., Paoletti R., Apitz-Castro R., Gelb M.H., and Corsini A. Ajoene, a garlic compound, inhibits protein prenylation and arterial smooth muscle cell proliferation. Br. J. Pharmacol. 138 (2003) 811-818
6. Hattori T., Furuta K., Nagao T., Nagamatsu T., Ito M., and Suzuki Y. Studies on the antinephritic effect of plant components (4): Reduction of protein excretion by berberine and coptisine in rats with original-type anti-GBM nephritis. Jpn. J. Pharmacol. 59 (1992) 159-169
7. Hikiami H., Kohta K., Sekiya N., Shimada Y., Itoh T., and Terasawa K. Erythrocyte deformability in "oketsu" syndrome and its relation to erythrocyte viscoelasticity. J. Trad. Med. 13 (1996) 156-164
8. Hirano H., Osawa E., Yamaoka Y., and Yokoi T. Gastric-mucous membrane protection activity of coptisine derivatives. Biol. Pharm. Bull. 24 (2001) 1277-1281
9. Hu J.P., Takahashi N., and Yamada T. Coptidis rhizoma inhibits growth and proteases of oral bacteria. Oral Dis. 6 (2000) 297-302
10. Iizuka N., Miyamoto K., Okita K., Tangoku A., Hayashi H., Yosino S., Abe T., Morioka T., Hazama S., and Oka M. Inhibitory effect of Coptidis rhizoma and berberine on the proliferation of human esophageal cancer cell lines. Cancer Lett. 148 (2000) 19-25
11. Iizuka N., Miyamoto K., Hazama S., Yoshino S., Yoshimura K., Okita K., Fukumoto T., Yamamoto S., Tangoku A., and Oka M. Anticachectic effects of Coptidis rhizoma, an anti-inflammatory herb, on esophageal cancer cells that produce interleukin 6. Cancer Lett. 158 (2000) 35-41
12. Kase Y., Saitoh K., Makino B., Hashimoto K., Ishige A., and Komatsu Y. Relationship between the antidiarrhoeal effects of Hange-Shashin-To and its active components. Phytother. Res. 13 (1999) 468-473
13. Ko W.H., Yao X.Q., Lau C.W., Law W.I., Chen Z.Y., Kwok W., Ho K., and Huang Y. Vasorelaxant and antiproliferative effects of berberine. Eur. J. Pharmacol. 399 (2000) 187-196
14. Kobayashi S., Mimura Y., Notoya K., Kimura I., and Kimura M. Antiproliferative effects of the traditional Chinese medicine Shimotsu-to, its component cnidium rhizoma and derived compounds on primary cultures of mouse aorta smooth muscle cells. Jpn. J. Pharmcol. 60 (1992) 397-401
15. Kohta K., Hiyama Y., Terasawa K., Hamazaki T., Itoh T., and Tosa H. Hemorrheological studies of "oketsu" syndrome - Erythrocyte aggregation in "oketsu" syndrome. J. Med. Pharm. Soc. WAKAN-YAKU 9 (1992) 221-228
16. Lin C.C., Ng L.T., Hsu F.F., Shieh D.E., and Chiang L.C. Cytotoxic effects of Coptis chinensis and Epimedium sagittatum extracts and their major constituents (berberine, coptisine, and icariin) on hepatoma and leukaemia cell growth. Clin. Exp. Pharmacol. Physiol. 31 (2004) 65-69
17. Mack C.P., Thompson M.M., Lawrenz-Smith S., and Owens G.K. Smooth muscle α-actin CArG elements coordinate formation of a smooth muscle cell-selective, serum response factor-containing activation complex. Circ. Res. 86 (2000) 221-232
18. Nandi R., Debnath D., and Maiti M. Interactions of berberine with poly(A) and tRNA. Biochim. Biophys. Acta 1049 (1990) 339-342
19. Ro J.S., Lee S.S., Lee K.S., and Lee M.K. Inhibition of type A monoamine oxidase by coptisine in mouse brain. Life Sci. 70 (2001) 639-645
20. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
21. Shin J.S., Kim E.I., Kai M., and Lee M.K. Inhibition of dopamine biosynthesis by protoberberine alkaloids in PC12 cells. Neurochem. Res. 25 (2000) 363-368
22. Takase H., Imanishi K., Miura O., Yumioka E., and Watanabe H. Features of the anti-ulcer effects of Oren-gedoku-to (a traditional Chinese medicine) and its component herb drugs. Jpn. J. Pharmacol. 49 (1989) 301-308
23. Tanaka T., Metori K., Mineo S., Hirotani M., Furuya T., and Kobayashi S. Inhibitory effects of berberine-type alkaloids on elastase. Planta Med. 59 (1993) 200-202
24. Terasawa K., Toriizuka K., Tosa H., Ueno M., Hayashi T., and Shimizu M. Rheological studies on "oketsu" syndrome I. The blood viscosity and diagnostic criteria. J. Med. Pharm. Soc. WAKAN-YAKU 3 (1986) 98-104
25. Yakazu D. Considerations on Oketsu (stagnation of disordered blood), one of the cardinal pathogenetic factors in oriental medicine. J. Japan Soc. Oriental Med. 25 (1975) 167-187
26. Zhan Y.H., Fang L.H., and Ku B.S. Fangchinoline inhibits rat aortic vascular smooth muscle cell proliferation and cell cycle progression through inhibition of ERK1/2 activation and c-fos expression. Biochem. Pharmacol. 66 (2003) 1853-1860